These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 25242754)

  • 1. Multidrug-resistance 1 gene single-nucleotide polymorphisms do not influence long-term graft survival after kidney transplantation.
    Saracino A; Muscaridola N; Cifarelli RA; Stallone G; Grandaliano G; Santarsia G
    Transplant Proc; 2014 Sep; 46(7):2214-9. PubMed ID: 25242754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms in CYP3A5 and MDR1 genes and their correlations with plasma levels of tacrolimus and cyclosporine in renal transplant recipients.
    Mendes J; Martinho A; Simoes O; Mota A; Breitenfeld L; Pais L
    Transplant Proc; 2009 Apr; 41(3):840-2. PubMed ID: 19376366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of multidrug resistance gene (MDR1) and cyclosporine absorption in de novo renal transplant patients.
    Foote CJ; Greer W; Kiberd B; Fraser A; Lawen J; Nashan B; Belitsky P
    Transplantation; 2007 May; 83(10):1380-4. PubMed ID: 17519790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistant 1 (MDR1) C3435T and G2677T gene polymorphism: impact on the risk of acute rejection in pediatric kidney transplant recipients.
    Korkor MS; El-Desoky T; Mosaad YM; Salah DM; Hammad A
    Ital J Pediatr; 2023 May; 49(1):57. PubMed ID: 37198710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation.
    Anglicheau D; Thervet E; Etienne I; Hurault De Ligny B; Le Meur Y; Touchard G; Büchler M; Laurent-Puig P; Tregouet D; Beaune P; Daly A; Legendre C; Marquet P
    Clin Pharmacol Ther; 2004 May; 75(5):422-33. PubMed ID: 15116055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine A in patients with steroid resistant ulcerative colitis.
    Daniel F; Loriot MA; Seksik P; Cosnes J; Gornet JM; Lémann M; Fein F; Vernier-Massouille G; De Vos M; Boureille A; Treton X; Flourié B; Roblin X; Louis E; Zerbib F; Beaune P; Marteau P
    Inflamm Bowel Dis; 2007 Jan; 13(1):19-23. PubMed ID: 17206635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDR1 C3435T polymorphisms correlate with cyclosporine levels in de novo renal recipients.
    Foote CJ; Greer W; Kiberd BA; Fraser A; Lawen J; Nashan B; Belitsky P
    Transplant Proc; 2006 Nov; 38(9):2847-9. PubMed ID: 17112845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of MDR1 gene polymorphisms for tacrolimus dosage.
    Kravljaca M; Perovic V; Pravica V; Brkovic V; Milinkovic M; Lausevic M; Naumovic R
    Eur J Pharm Sci; 2016 Feb; 83():109-13. PubMed ID: 26705892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between cyclosporine concentration and genetic polymorphisms of CYP3A5 and MDR1 during the early stage after renal transplantation.
    Azarpira N; Aghdaie MH; Behzad-Behbahanie A; Geramizadeh B; Behzadi S; Malekhoseinie SA; Raisjalal GH; Rahsaz M; Pourgholami A; Sagheb F
    Exp Clin Transplant; 2006 Jun; 4(1):416-9. PubMed ID: 16827636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors Affecting Graft and Patient Survivals After Transplantation From Deceased Donors in a Developing Country: A Single-Center Experience.
    Ayar Y; Ersoy A; Ocakoglu G; Yildiz A; Oruc A; Soyak H; Calapkulu M; Sahin AB; Topal NB; Okeer E; Coskun B; Kaygisiz O; Kordan Y; Vuruskan H
    Transplant Proc; 2017 Mar; 49(2):270-277. PubMed ID: 28219583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients.
    Anglicheau D; Verstuyft C; Laurent-Puig P; Becquemont L; Schlageter MH; Cassinat B; Beaune P; Legendre C; Thervet E
    J Am Soc Nephrol; 2003 Jul; 14(7):1889-96. PubMed ID: 12819250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of MDR1 gene polymorphisms on mortality in paraquat intoxicated patients.
    Kim HJ; Kim HK; Kwon JT; Lee SH; El Park S; Gil HW; Song HY; Hong SY
    Sci Rep; 2016 Aug; 6():31765. PubMed ID: 27545861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten-year kidney transplant survival of cyclosporine- or tacrolimus-treated patients in Brazil.
    Gomes RM; Guerra Júnior AA; Lemos LL; Costa Jde O; Almeida AM; Alvares J; Filho CS; Cherchiglia ML; Andrade EI; Godman B; Acurcio FA
    Expert Rev Clin Pharmacol; 2016 Jul; 9(7):991-9. PubMed ID: 27181131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant impact of gene polymorphisms on tacrolimus but not cyclosporine dosing in Asian renal transplant recipients.
    Loh PT; Lou HX; Zhao Y; Chin YM; Vathsala A
    Transplant Proc; 2008 Jun; 40(5):1690-5. PubMed ID: 18589174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diltiazem augments the influence of MDR1 genotype status on cyclosporine concentration in Chinese patients with renal transplantation.
    Wang YX; Li JL; Wang XD; Zhang Y; Wang CX; Huang M
    Acta Pharmacol Sin; 2015 Jul; 36(7):855-62. PubMed ID: 25891084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft survival following living-donor renal transplantation: a comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids.
    Bunnapradist S; Daswani A; Takemoto SK
    Transplantation; 2003 Jul; 76(1):10-5. PubMed ID: 12865780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analysis of MDR1 and inflammatory bowel disease reveals protective effect of heterozygous variants for ulcerative colitis.
    Huebner C; Browning BL; Petermann I; Han DY; Philpott M; Barclay M; Gearry R; McCulloch A; Demmers P; Ferguson LR
    Inflamm Bowel Dis; 2009 Dec; 15(12):1784-93. PubMed ID: 19685447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in newly diagnosed patients with chronic myeloid leukemia.
    Harivenkatesh N; Kumar L; Bakhshi S; Sharma A; Kabra M; Velpandian T; Gogia A; Shastri SS; Biswas NR; Gupta YK
    Pharmacol Res; 2017 Jun; 120():138-145. PubMed ID: 28330783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.